Skip to main content

What the FDA labels say about taking them together

Esomeprazole and lapatinib ditosylate

Lapatinib ditosylate's FDA label of November 30, 2023 names esomeprazole in its drug interactions section; the esomeprazole labels PlainMeds reads (3) do not name lapatinib ditosylate. The lapatinib ditosylate label: “However, esomeprazole, a proton pump inhibitor, administered at a dose of 40 mg once daily for 7 days, did not result in a clinically meaningful reduction in lapatinib steady-state exposure.”

Check it at the source: the esomeprazole FDA label on DailyMed (effective March 19, 2024, Haleon US Holdings LLC); the lapatinib ditosylate FDA label on DailyMed (effective November 30, 2023, Teva Pharmaceuticals, Inc.).

What does the esomeprazole label say about lapatinib ditosylate?

Esomeprazole's label (effective March 19, 2024) and its 2 other brand-application labels do not name lapatinib ditosylate in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Nexium 24HR), NDA204655 (Astrazeneca Lp), as published by Haleon US Holdings LLC, effective March 19, 2024 (SPL set 4513934d-0cf0-40fc-a348-b4e75a33b094), via openFDA; the full label on DailyMed

What does the lapatinib ditosylate label say about esomeprazole?

Lapatinib ditosylate label, drug interactions

However, esomeprazole, a proton pump inhibitor, administered at a dose of 40 mg once daily for 7 days, did not result in a clinically meaningful reduction in lapatinib steady-state exposure.

Source: FDA drug label (Lapatinib), Teva Pharmaceuticals, Inc., effective November 30, 2023 (SPL set b09abf73-1eef-4e12-b400-c030d546d223), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

116Esomeprazole generic labelers
3Lapatinib ditosylate generic labelers
EsomeprazoleLapatinib ditosylate
Labeled forAcid reflux and ulcersBreast cancer
Boxed warningNoYes
Pharmacy cost (NADAC)$0.145 per capsule 20 mg capsulen/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?